Beyond Biotech - the podcast from Labiotech
Beyond Biotech podcast 58: Pepteins
Aug 11, 2023
In this episode, Christian Schwarz, CEO and co-founder of Numaferm, shares insights on pepteins, an underdeveloped class of molecules with high biological activity. They discuss the challenges of manufacturing pepteins, their potential applications in various industries, and the unique biochemical production platform developed by Numaferm. The podcast also explores the use of peptides and nanobodies in drug development and the role of artificial intelligence in protein and peptide development. Additionally, they touch upon global market presence, regulatory issues, and sustainability changes.
19:56
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Pep-teens, a niche between peptides and proteins, have unique functionalities and characteristics, and their application potential extends to industries such as synthetic meat, drug development, and vaccines against diseases like COVID-19.
- Numaferm offers a revolutionary production platform for pep-teens using a biochemical system that trains cells to produce them without aggregation, providing cost-effective and efficient methods for industries like pharmaceuticals, biotech, agriculture, and cosmetics.
Deep dives
What are pep-teens?
Pep-teens are a newly created term to describe a niche between peptides and proteins. They have unique functionalities and characteristics, being smaller than proteins but larger than peptides. The manufacturing of pep-teens is challenging, as chemical synthesis and microbial systems struggle to produce them efficiently. The application of pep-teens is currently limited but shows potential in various areas such as the synthetic meat industry, drug development, and vaccines against diseases like COVID-19.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
